A spray treatment which can prolong intercourse time by at least six-fold by delaying orgasm in prematurely ejaculating men has been developed by a Japanese company Shionogi unit Sciele Pharma Inc. The investigational drug code-named PSD502 combines two local anesthetics - lidocaine and prilocaine - in an aerosol applied to the ...

CYT006-AngQb is a therapeutic vaccine designed to evoke an antibody response against angiotensin II

Abraxane delivers higher doses of anti-cancer drug paclitaxel using nano delivery

Udenafil  has a  faster  onset of action  and  can be effective for up to 24 hours

Atazanavir, a protease inhibitor drug by Bristol-Myers Squibb Company has been shown effective in adult patients infected with HIV-1, who are previously untreated.

Tezampanel, a non opium based pain killer by Raptor Pharmaceutical Corporation, has been found effective in dealing with acute migraine and other neuropathic pain. 

Laninamivir, an inhaled drug to treat H1N1 swine flu, is also found effective against H5N1 avian influenza

Clotrimazole, current treatment against oral candidiasis is administered five times a day

TNFerade, an investigational drug against pancreatic cancer, has been awarded Orphan Drug status providing potential financial and regulatory incentives by the U.S. Food and Drug Administration, its maker GenVec announced in a press statement.

Stimuvax, an experimental therapeutic vaccine the stimulate immune cell to fight cancer from Merck KGaA of Germany, has been found  promising enough to treat several cancers including breast tumours and lung cancer.